ATB Therapeutics

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Health and bio

Funding rounds

1. December 2, 2024
   Series A · $57M
   EEQT Life Sciences (lead), MMRL Ventures Fund (lead), SSambrinvest, SSFPIM, VV-Bio Ventures, VVIVES Funds, WWE International
   Source: startupintros.com
2. October 2, 2017
   Website created

Founders and team

• BM
  Bertrand Magy Founder

  LinkedIn
• MH
  Max Houry Founder

  LinkedIn
• MT
  Mark Throsby Chief Executive Officer

Investors

• EEQT Life Scienceslead investor
• FFinancière Spin-Off Luxembourgeoise
• FFournier-Majoie
• MMRL Ventures Fundlead investor
• SSambrinvest
• SSFPIM
• VV-Bio Ventures
• VVIVES Funds
• WWalloon
• WWE International

Companies like ATB Therapeutics

• AAdcytherixSeries A · Oct 2025
• OOncoC4$50M Series B+ · Oct 2025
• DDren Bio$350M Series B+ · Oct 2026
• DDomain Therapeutics$41M Series A · May 2022
• OOna Therapeutics$86.6M Series B+ · Oct 2026
• PPersevere Therapeutics$1.5M Seed · Mar 2026

Other companies backed by EQT Life Sciences

• NNouscom$135.04M Series B+ · Oct 2026
• VVaderis Therapeutics$152M Series B+ · Aug 2026
• RRQ Bio$115M Series A · Jun 2026
• KKinaset Therapeutics$103M Series B+ · Jan 2026
• FFoRx Therapeutics$50M Series A · Dec 2025
• TTubulis$360M Series B+ · Oct 2025

EQT Life Sciences portfolio →